Bonus Oct 18, 1999 Nov 05, 1999 Oct 07, 1999 Bonus Ratio: 2 share(s) for every 1 shares held Rights Feb 03, 1995 Mar 02, 1995 May 03, 1995 Rights ratio: 4 share for every 50 held at a price of Rs ...

Cipla Limited is one of the leading pharmaceutical companies in India. The Company is in the business of manufacturing developing and marketing wide range of branded and generic formulations and ...

For the quarter, net profit soared 49% on-year to ₹1,570 crore, on the back of higher revenue and better operating efficiency.

The Capital Structure page of Cipla Ltd. presents the Authorized Capital, Issued Capital, and Paid-Up Equity Capital of the company over the period.

Sustainalytics’ Controversies Research identifies companies involved in incidents and events that may negatively impact stakeholders, the environment or the company’s operations. Controversies ...

Earnings Per Share (TTM) A company's net income for the trailing twelve month period expressed as a dollar amount per fully diluted shares outstanding. Market Capitalization Reflects the total ...

Sun Pharma is projected to lead in PAT growth at 28% YoY, while Cipla might see a 5% YoY decline, according to Centrum ...

The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.

Cipla Medpro faces legal restrictions after the Western Cape High Court ruled that its trade name Furizome infringes on ...

Tata Power Company Limited is Indias largest integrated private power company, with a significant international presence. The Company was incorporated in September, 1919 and became a pioneer in ...

Cipla Medpro faces legal restrictions after the Cape Town High Court ruled that its trade name Furizome infringes on Adcock ...